Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


340B Dispute Resolution Rule Likely Violated Proper Regulatory Procedures – Court

Executive Summary

Ruling halts the 340B rule, and may have relevance in a suit brought by PBMs challenging the ‘rebate rule,’ which was issued in final form after HHS had suspended action on the reg.

You may also be interested in...

Medicare Part D Rebate Rule Delayed Until 2023 As PBMs Notch Legal Win

HHS initially postponed only those provisions of the final regulation that were scheduled to go into effect 29 January, but Biden Administration now faces April deadline from court to determine how to proceed with the rest of the rule.

340B Dispute Resolution Process On Ice As Feuds Between Pharma, Providers, HHS Heat Up

Biden Administration’s regulatory freeze suspends HHS action to appoint an administrative dispute resolution board for the 340B program. Good news for manufacturers?

340B Needs A Stronger Fix Than Dispute Resolution Rule, Provider Lawsuit Against HHS Argues

Drug manufacturer actions against contract pharmacies require immediate attention, provider suit says, though HHS’ 340B dispute resolution process ‘holds promise.’


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts